Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of sacubitril-valsartan compared to the
combination of ARB/CCB on left ventricular remodeling in patients with chronic aortic valve
regurgitation.
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Amlodipine Losartan Sacubitril and valsartan sodium hydrate drug combination Valsartan